Cargando…
A review of treatments targeting DNA-repair gene defects in metastatic castration resistant prostate cancer
Prostate cancer is the most common cancer in men. About 6% of those diagnosed will develop metastatic disease. Unfortunately, metastatic prostate cancer is fatal. Prostate cancer can be castration sensitive or castration resistant. Many treatments have been shown to improve progression free survival...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046303/ https://www.ncbi.nlm.nih.gov/pubmed/36998466 http://dx.doi.org/10.3389/fonc.2023.1150777 |